Hershey, PANCT06175000Now EnrollingIRB Ready

Central Nervous System Lymphoma Clinical Trial in Hershey, PA

Access cutting-edge central nervous system lymphoma treatment through this clinical trial at a research site in Hershey. Study-provided care at no cost to qualified participants.

Sponsored by Providence Health & Services

Quick Self-Assessment

See if you qualify for this Hershey location

Preparing your pre-screening questions...

Expert Care in Hershey

Access central nervous system lymphoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related central nervous system lymphoma treatment provided free

Apply for This Hershey Location

Check if you qualify for this central nervous system lymphoma clinical trial in Hershey, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Hershey

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Hershey site if eligible
  4. 4Begin participation

About This Central Nervous System Lymphoma Study in Hershey

This randomized phase II trial studies how well obinutuzumab works as maintenance treatment in patients with central nervous system lymphoma who have achieved the disappearance of all signs of cancer in response to treatment (complete response) or a decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment (partial response). Immunotherapy with obinutuzumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to gro

Sponsor: Providence Health & Services

Who Can Participate

Inclusion Criteria

CD20+ B-cell primary central nervous system lymphoma (PCNSL) confirmed at the time of diagnosis by histology, cytology, or immunocytochemistry from cerebrospinal fluid (CSF); diagnosis must be documented by pathology report.
Must have undergone first-line treatment with a high-dose methotrexate-based chemotherapy regimen with or without brain radiotherapy; high-dose methotrexate is defined as \>= 3 grams/m\^2; methotrexate dose reduction for creatinine clearance \< 100 ml/min is permitted
Must be within 75 days of completion of first-line treatment regimen at the time of randomization; must have achieved objective response (PR or CR/unconfirmed complete response \[CRu\]) to first-line treatment
Brain magnetic resonance imaging (MRI) documenting objective response must be obtained within 30 days before randomization
If CSF was positive for lymphoma cells at diagnosis or during first-line treatment and/or a slit lamp examination was positive at diagnosis or

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Hershey?

Yes, this clinical trial (NCT06175000) has an active research site in Hershey, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Central Nervous System Lymphoma Treatment Options in Hershey, PA

If you're searching for central nervous system lymphoma treatment options in Hershey, PA, this clinical trial (NCT06175000) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Hershey research site is actively enrolling participants for this clinical trial. You'll receive care from experienced central nervous system lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all central nervous system lymphoma clinical trials near you to find additional studies recruiting in your area.

More Lymphoma Trials in Hershey, PA

See all lymphoma clinical trials recruiting in Hershey — not just this study.

Browse Lymphoma Trials in Hershey

Ready to Join in Hershey?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Hershey, PA